Trial Profile
Head-to-head comparison of Subcutaneous Tocilizumab versus Abatacept for Rheumatoid arthritis : prospective, randomized trial.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2015
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms STAR study
- 24 Sep 2014 New trial record